About Us.
GenoTwin combines genomics, AI, and data science to transform how medical professionals diagnose, monitor, and treat pathogens with comprehensive insights.
From genomics expertise to precision medicine
GenoTwin was founded on a simple insight: traditional pathogen testing misses critical information about how the immune system responds. We built a platform that characterizes both pathogen and host together, giving medical professionals, researchers, and public health officials the complete picture they need to diagnose, monitor, and treat disease.
The Current Landscape
Traditional pathogen tests (e.g., RT-PCR) do not provide the critical information that clinicians, public health officials, and researchers need to fully guide their decisions.
Address only one or a few pathogens at a time, leaving gaps in detection and making it harder to catch co-infections or emerging threats early.
Questions about GenoTwin
Find answers about our platform, testing approach, and how we serve medical professionals and public health officials.
What makes GenoTwin's testing different from traditional pathogen detection?
GenoTwin characterizes both the pathogen and your immune response simultaneously. Traditional methods focus on the pathogen alone. This dual approach reveals how your immune system interacts with infection, enabling precision diagnosis and treatment decisions that standard testing cannot provide.
Who uses GenoTwin's platform?
Medical professionals, researchers, and public health officials use GenoTwin to diagnose pathogens, monitor disease progression, and inform patient care decisions. Our insights support individual treatment planning and population-level surveillance for pathogen-based cancers and infectious diseases.
How does GenoTwin integrate genomics and AI?
We combine genomic sequencing with data science and artificial intelligence to process complex pathogen and immune data. This integration identifies patterns humans cannot detect alone, translating raw genomic information into actionable clinical and epidemiological insights.
Can GenoTwin help with pathogen-based cancer monitoring?
Yes. GenoTwin supports surveillance and monitoring of pathogen-based cancers by characterizing both the pathogen and host immunity. This comprehensive view helps clinicians understand disease drivers and make informed decisions about precision treatment and follow-up care.
How does GenoTwin contribute to public health decision-making?
GenoTwin provides data-rich pathogen and immuno-surveillance insights that inform policy and individual patient care. By integrating advanced genomic data into public health workflows, we enable enlightened decision-making at both population and clinical levels.
Where is GenoTwin based?
GenoTwin is headquartered in New York City. Our team combines expertise in genomics, computational biology, data science, and artificial intelligence to develop and refine our next-generation testing platform.
Ready to learn more?
Reach out to discuss how GenoTwin can support your diagnostic or research needs.